| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |